Stephen Comiskey,Rong Feng,John Foss,Kunwar Shailubhai
申请号：
US16356259
公开号：
US20190321439A1
申请日:
2019.03.18
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
